Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
CH0014284498
Mon, 23.12.2024
Siegfried AG
Siegfried AG
/ Key word(s): Sustainability
Siegfried once again confirmed in the Dow Jones Sustainability Index Europe 23.12.2024 / 06:30 CET/CEST
Media Release
Zofingen, December 23, 2024
The DJSI is a highly regarded benchmark for evaluating corporate progress in environmental, social, and governance (ESG) performance across [ … ]
Fri, 06.12.2024
Siegfried AG
Siegfried AG
/ Key word(s): Personnel
Changes in Siegfried's senior management team 06.12.2024 / 06:30 CET/CEST
Media Release
Zofingen, December 6, 2024
Stefan Randl will join as Chief Scientific Officer and member of the Executive Committee as of January 1, 2025. He will succeed Jürgen Roos who has decided to leave the compan [ … ]
Tue, 19.11.2024
Siegfried AG
Siegfried AG
/ Key word(s): Expansion
Siegfried opens new global R&D Center for Drug Substances in Evionnaz 19.11.2024 / 07:03 CET/CEST
Media Release
Zofingen, November 19, 2024
Siegfried (SIX: SFZN), a leading global Contract Development and Manufacturing Organization (CDMO) for the pharmaceutical industry headquartered i [ … ]
Tue, 12.11.2024
Siegfried AG
Siegfried AG
/ Key word(s): Expansion
DINAMIQS opens new lab in Zurich 12.11.2024 / 06:30 CET/CEST
Media Release
Zofingen, November 12, 2024
Siegfried (SIX: SFZN), a leading global Contract Development and Manufacturing Organization (CDMO) for the pharmaceutical industry headquartered in Zofingen (Switzerland), reached another [ … ]
Thu, 24.10.2024
Siegfried AG
Siegfried AG
/ Key word(s): Strategic Company Decision
Strategy EVOLVE+ paves the way for continued profitable growth 24.10.2024 / 06:30 CET/CEST
Media Release
Zofingen, October 24, 2024
Siegfried (SIX: SFZN), a leading global Contract Development and Manufacturing Organization (CDMO) for the pharmaceutical industry headquarte [ … ]
Wed, 04.09.2024
Siegfried AG
EGS Beteiligungen AG exercised its right to convert also the second of the two convertible bonds issued in December 2020 with a coupon of 1.15% and a nominal value of CHF 40m into shares of Siegfried Holding AG. EGS Beteiligungen AG will receive 48'054 shares and as a result will increase its stake in Siegfried from 6.2% to about 7.2% registered sh [ … ]
Fri, 30.08.2024
Siegfried AG
Siegfried AG
/ Key word(s): Miscellaneous
Siegfried opens new quality control lab in Minden 30.08.2024 / 06:30 CET/CEST
Siegfried inaugurated its new state-of-the-art quality control lab in Minden. The new facility further improves the operational efficiency and readies the site for the completion of the new large-scale produc [ … ]
Thu, 22.08.2024
Siegfried AG
In the first half of 2024, Siegfried (SIX: SFZN) continued its journey of profitable growth. Significant progress has been made in the implementation of the corporate strategy EVOLVE which is geared towards long-term profitable growth in core areas and beyond.
Net sales amounted to CHF 619.9 million, an increase of 3.5% in local currencies (2.1% i [ … ]
Wed, 10.07.2024
Siegfried AG
The Board of Directors of Siegfried Holding AG has appointed Marcel Imwinkelried as the new CEO with effect as of September 1, 2024. He will succeed Reto Suter, who has been leading the Siegfried Group as CEO ad interim since May 1, 2024, and will now focus again on his role as CFO.
Marcel Imwinkelried (1967) joined the Siegfried Group in January 2 [ … ]
Tue, 02.07.2024
Siegfried AG
Siegfried AG
/ Key word(s): Acquisition
Siegfried successfully completes acquisition of an early-phase CDMO in Wisconsin (US) 02.07.2024 / 06:30 CET/CEST
Siegfried (SIX: SFZN) has completed the acquisition of an early-phase CDMO site in Grafton, Wisconsin (US) from Curia Global, strengthening Siegfried's customer offering for [ … ]